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E611–E617, 1998.—Insulin stimulates amiloride-sensitive
sodium transport in models of the distal nephron. Here we
demonstrate that, in the A6 cell line, this action is mediated
by the insulin receptor tyrosine kinase and that activation of
phosphatidylinositol 3-kinase (PI 3-kinase) lies downstream
of the receptor tyrosine kinase. Functionally, a specific inhibi-
tor of PI 3-kinase, LY-294002, blocks basal as well as insulin-
stimulated sodium transport in a dose-dependent manner
(IC50 < 6 µM). Biochemically, PI 3-kinase is present in A6
cells and is inhibited both in vivo and in vitro by LY-294002.
Furthermore, a subsequent potential downstream signaling
element, pp70 S6 kinase, is activated in response to insulin
but does not appear to be part of the pathway involved in
insulin-stimulated sodium transport. Together with previous
reports, these results suggest that insulin may induce the
exocytotic insertion of sodium channels into the apical mem-
brane of A6 cells in a PI 3-kinase-mediated manner.
amiloride-sensitive sodium channel; insulin signaling; recep-
tor tyrosine kinase; renal epithelia
INSULIN INCREASES SODIUM REABSORPTION in dogs and
humans, and this effect appears to be manifested
predominantly on the renal distal nephron (21, 10).
Models of the distal nephron, toad urinary bladder
(Bufo marinus) and the A6 cell line (derived from
Xenopus laevis kidney), have been used to demonstrate
a direct effect of insulin on amiloride-sensitive sodium
transport (12, 14). Patch-clamp electrophysiology has
indicated that insulin causes an increase in the open
probability (PO) of the apical sodium channel (20).
However, blocker-induced noise analysis demonstrated
that insulin induces an increase in active sodium
channel density in the apical membrane (2, 4, 11). In
addition, insulin increases the apical membrane area
(11). These results suggest that insulin may induce the
insertion of sodium channels into the apical membrane,
a hypothesis supported by our study demonstrating
that brefeldin A, an inhibitor of secretion, partially
inhibits insulin-stimulated sodium transport (9).
The first step in insulin signaling is the binding of the
hormone to its receptor, followed by autophosphoryla-
tion of the receptor and subsequent activation of the
receptor tyrosine kinase (IRTK). IRTK has several
substrates, including the insulin receptor substrate
(IRS) proteins (33). The IRS proteins mediate some of
the pleiotropic effects of insulin through interactions
with proteins containing SH2 domains, including phos-
phatidylinositol 3-kinase (PI 3-kinase). This enzyme, a
heterodimer, phosphorylates the D-3 position of the
myo-inositol ring of phosphatidylinositols (PtdIns; 17).
PI 3-kinase is required for several insulin-mediated
effects, including the translocation of the insulin-
responsive glucose transporter (GLUT-4) to the plasma
membrane of adipocytes (7) and skeletal muscle (34),
and the activation of pp70 S6 kinase, which is neces-
sary for protein synthesis (24).
We have previously demonstrated that insulin binds
to the basolateral membrane of amphibian cells (5) and,
along with others, that genistein, a tyrosine kinase
inhibitor, decreases insulin-stimulated sodium trans-
port (25, 27). Here we demonstrate that, in A6 cells, an
IRTK inhibitor blocks insulin-stimulated sodium trans-
port and that a specific PI 3-kinase inhibitor blocks
insulin-stimulated sodium transport in a dose-depen-
dent manner. We also show that, in the A6 cell line,
insulin stimulates PI 3-kinase in vivo. In addition, our
functional and biochemical studies indicate that pp70
S6 kinase is present in these cells and is activated by
insulin but is not involved in insulin-stimulated so-
dium transport. These results suggest that PI 3-kinase
is necessary for insulin-stimulated sodium transport,
perhaps by mediating the insertion of sodium channels
into the apical membrane in a manner analogous to the
insulin-stimulated insertion of GLUT-4.
EXPERIMENTAL PROCEDURES
Materials. Hydroxy-2-naphthalenylmethylphosphonic acid
tris acetoxymethyl ester [HNMPA-(AM)3] and 2-(4-morpholi-
nyl)-8-phenyl-4H-1-benzopyran-4-one (LY-294002) were pur-
chased from BIOMOL Research Laboratories. Wortmannin,
amiloride, PtdIns, and PBS were purchased from Sigma
Chemical. The wortmannin used has been shown to be active
against mammalian PI 3-kinase. [32P]H3PO4 was purchased
from Du Pont NEN. [g-32P]ATP was purchased from Amer-
sham Life Science. The anti-PI 3-kinase 85-kDa subunit,
anti-pp70 S6 kinase, S6 kinase substrate, and an inhibitor
cocktail for S6 kinase assay were purchased from Upstate
Biotechnology. Porcine insulin was a generous gift from Eli
Lilly. Rapamycin was purchased from ICN Pharmaceuticals.
Transwell inserts were purchased from Costar. GammaBind
Plus Sepharose beads were purchased from Pharmacia Bio-
tech. Silica gel thin-layer chromatography plates, 60A, were
purchased through Curtin Matheson Scientific. Media were
purchased from GIBCO-BRL Life Technologies. 4-(2-Amino-
ethyl)-benzenesulfonyl fluoride hydrochloride (AEBSF) was
obtained from Boehringer Mannheim.
Cell culture. The A6 cell line was obtained from American
Type Tissue Culture Collection and grown at 27°C in a
humidified incubator gassed with 5% CO2 in O2, as previously
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described (3). For electrophysiology, cells were subcultured
onto 24-mm Transwell inserts; for biochemistry, cells were
subcultured onto 24- or 100-mm Transwell inserts. Cells were
used 14–21 days after seeding.
Electrophysiology. Short-circuit current (SCC) techniques
were used to determine net ion flux (19, 22). Cells grown on
Transwell inserts were placed in a modified Ussing chamber
and monitored as previously described (3). During the electro-
physiological studies, cells were bathed in serum-free media
maintained at 27°C, with gentle circulation provided by a 5%
CO2-95% O2 gas lift. Four chambers allowed simultaneous
monitoring of cells grown in tandem. The monolayers were
monitored until a stable baseline SCC was obtained (typically
0.5–2 h). The average starting currents (after baseline stabi-
lization) in these experiments varied from 2.7 to 18.9 µA/cm2.
There was some variation between the starting currents in
the different sets of experiments; however, within each experi-
mental protocol, the average starting currents of the cells in
all conditions were statistically the same value. The addition
of amiloride at the end of each experiment verified that the
majority of the SCC was due to net apical-to-serosal Na1 flux,
as previously reported for A6 cells. Transcellular resistance
was determined every 2 min via a brief 2-mV pulse across the
cells. The average transcellular resistance varied from 1,372
to 3,075 V · cm2. None of the inhibitors caused a significant
decrease in the transepithelial resistance over the time
course of the experimental protocols.
Porcine insulin was added to the serosal bathing medium.
HNMPA-(AM)3, wortmannin, LY-294002, and rapamycin were
dissolved in DMSO and added bilaterally. Amiloride, dis-
solved in methanol, was added to the apical bathing medium.
Equal volumes of DMSO were added to the control tissues to
detect any carrier effects; none were detected.
The change in SCC (DSCC) in experimental (e) relative to
control (c) samples was calculated using the following for-
mula: DSCC 5 [SCC(t) 2 SCC(0)]e 2 [SCC(t) 2 SCC(0)]c,
where SCC(t) is SCC at time t after insulin addition (with or
without inhibitor preincubation), and SCC(0) is the SCC at
the time of insulin addition (with or without inhibitor pretreat-
ment).
PI 3-kinase assay, in vitro. PI 3-kinase activity was deter-
mined by measuring the transfer of 32P from [g-32P]ATP to PI
to form [32P]PI-3, which was detected by thin-layer chromatog-
raphy. A6 cells cultured on Transwell inserts were incubated
in serum-free media for 16 h. The cells were incubated with or
without 100 nM insulin in serum-free media for 5 min
followed by one wash with ice-cold PBS. Ice-cold immunopre-
cipitation buffer (10 mM Tris, pH 7.4, 1% Triton X-100, 150
mM NaCl, 0.5% nonidet P-40, 1 mM EDTA, 1 mM EGTA, 0.2
mM sodium vanadate, 0.2 mM AEBSF, 100 mM sodium
fluoride) was added to the filters, and the cells were scraped
off with a rubber policeman. The cells were transferred to
microtubes and incubated for 30 min at 4°C with occasional
vortexing. The samples were centrifuged (16,000 gmax) for 15
min in a cold room. The supernatant (containing soluble
proteins) was incubated with anti-PI 3-kinase (against the
85-kDa subunit) and GammaBind beads for 4 h at 4°C with
constant rotation. The beads were washed once in ice-cold
PBS; twice in 0.5 M LiCl, 0.1 M Tris, pH 7.5; and once in PI
3-kinase assay buffer (10 mM MgCl2 and 20 mM HEPES, pH
7.4).
The amount of PI 3-kinase activity in the immunoprecipita-
tions was determined as previously described (23). The
reaction was stopped with HCl, and the lipids were extracted
with methanol-chloroform (1:1 by volume). The lipids were
applied to a silica gel thin-layer chromatography plate; the
residue was developed with chloroform-methanol-water-
ammonium hydroxide (45:35:8.5:1.5 by volume). The plate
was dried and autoradiographed.
PI 3-kinase activity, in vivo. PI 3-kinase activity was
determined by directly measuring the insulin-stimulated
products of PI 3-kinase {[32P]I-3P, [32P]I-(3,4)P2, and [32P]I-
(3,4,5)P} by use of anion exchange chromatography and an
on-line radiochemical detector. A6 cells subcultured onto
100-mm Transwell inserts and grown to confluency were
incubated in serum-free media for 16 h. Subsequently, the
cells were incubated in phosphate-free media containing 0.5
mCi/plate [32P]H3PO4 for 2 h. The cells were incubated with or
without 25 nM wortmannin or 50 µM LY-294002 for 20 min.
The medium was removed, and the cells were washed twice
with phosphate-free medium with or without inhibitor. The
cells were incubated for 1 min in 100 nM insulin, serosally,
with or without inhibitor, followed by the addition of 1 N
HCl-methanol (1:1 by volume). The cells were scraped and the
lipids extracted as reported (13). After thin-layer chromatog-
raphy and autoradiography, the lipids were deacylated by
treatment with methylamine (8) and separated by anion-
exchange HPLC.
pp70 S6 kinase assay. A6 cells, serum starved for 16 h, were
treated for 30 min with or without 100 nM rapamycin
followed by 10 min in the presence or absence of 100 nM
insulin. Immunoprecipitations were performed as above,
with the inclusion of 10 mM b-glycerophosphate in the
immunoprecipitation buffer. A polyclonal antibody raised
against a peptide corresponding to a post-NH2-terminal re-
gion of the human pp70 S6 kinase was used for enzyme
isolation. The immunoprecipitates were washed three times
in immunoprecipitation buffer followed by two washes in S6
kinase assay buffer [(in mM) 20 MOPS, pH 7.2, 25 b-
glycerophosphate, 5 EGTA, 1 orthovanadate, 1 dithiothrei-
tol]. The washed immunoprecipitates were incubated in 10 µl
of S6 kinase assay buffer, 10 µl inhibitor cocktail, 10 µl S6
kinase assay buffer with or without substrate (11-amino acid
peptide), and 10 µl of [g-32P]ATP mixture (0.2 mCi/ml, 112.5
µM ATP, 16.9 mM MgCl2, final concentrations) for 20 min at
30°C. An aliquot of the reaction mixture was placed on
phosphocellulose paper followed by three washes in 0.7%
phosphoric acid and one wash in acetone. The radioactivity
was determined with a scintillation counter. Samples without
immunoprecipitates (blanks) were run for background deter-
minations. All samples were run in duplicate and averaged.
The blanks were subtracted from the samples, and the
endogenous substrate activity (samples without added sub-
strate) was subtracted from the specific substrate activity.
RESULTS
We previously demonstrated that insulin binds to the
basolateral membrane and that the insulin receptor is
predominantly localized to the same membrane of
amphibian cells (5). To demonstrate that insulin-
stimulated sodium transport requires the IRTK, we
added HNMPA-(AM)3 (5 µg/ml), a specific inhibitor of
IRTK (1), 60 min before the addition of 20 nM insulin
(Fig. 1). HNMPA-(AM)3 inhibited insulin-stimulated
sodium transport ,50%. This suggests that insulin
stimulation of sodium transport is mediated through
IRTK.
Earlier studies by us and others (2, 4, 11) have
demonstrated that insulin stimulates an increase in
the number of active sodium channels into the apical
membrane. Insulin induces the insertion of GLUT-4,
another transporter, into the plasma membrane in a PI
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3-kinase-dependent manner (7, 34). To investigate
whether PI 3-kinase was necessary for insulin-stimu-
lated sodium transport, we initially used wortmannin,
a fungal metabolite, which inhibits PI 3-kinase with an
IC50 of 1.8–4.0 nM in 3T3 cells (23). However, 25 nM
wortmannin did not inhibit insulin-stimulated sodium
transport (Fig. 2). At a concentration of 100 nM,
wortmannin had an effect on basal transport and
partially inhibited only the initial (30-min) response to
insulin (Fig. 2).
A more specific inhibitor of PI 3-kinase, LY-294002
(32), blocked both basal and insulin-stimulated sodium
transport in a dose-dependent manner (Fig. 3). The
lowest concentration, 2 µM, had no effect, whereas 50
µM inhibited ,90% of insulin-stimulated sodium trans-
port. Graphing this limited dose-response curve yielded
an IC50 of ,6 µM (Fig. 4), which is comparable to the
reported IC50 of 1.4 µM (32).
The effects of insulin on transcellular Na1 transport
are manifested quite rapidly. Figure 5 illustrates the
very early time course of the insulin response. Because
activation of the signal transduction mechanism would
be expected to precede the final effect on ion flux, the
biochemical assays were designed to examine effects
within the early phase of the insulin response.
To determine whether the LY-294002 effect was due
to PI 3-kinase inhibition, we immunoprecipitated PI
3-kinase from A6 cells and assayed the activity associ-
ated with the immunoprecipitates (Fig. 6). In agree-
ment with the electrophysiology studies, immunopre-
cipitated PI 3-kinase activity was inhibited by 50 µM
LY-294002, whereas wortmannin (25 nM) had little or
no effect. As has been reported (31), treating the cells
with insulin did not increase the amount of PI 3-kinase
activity in immunoprecipitates.
We also examined the ability of insulin to stimulate
the formation of D-3 phosphorylated phosphoinositides
in vivo. As seen in Fig. 7, PtdIns(3)P, PtdIns(3,4)P, and
PtdIns(3,4,5)P increase with insulin treatment (100
nM; 1 min). Wortmannin (25 nM) inhibited the insulin-
stimulated formation of PtdIns(3)P and PtdIns(3,4)P
but not PtdIns(3,4,5)P. LY-294002 (50 µM) inhibited
production of all three products, preventing the forma-
tion of any detectable PtdIns(3,4,5)P. Together, these
results suggest that PI 3-kinase is present in A6 cells
and can be stimulated by insulin. Furthermore, the A6
cell PI 3-kinase is inhibited by LY-294002, partially
inhibited by wortmannin, and is critical for insulin-
stimulated sodium transport.
pp70 S6 kinase is one of the insulin-stimulated
elements downstream of PI 3-kinase necessary for
several metabolic actions (7). To determine whether
Fig. 1. Hydroxy-2-naphthalenylmethylphosphonic acid tris acetoxy-
methyl ester [HNMPA-(AM)3] inhibits insulin-stimulated sodium
transport. A6 cells were preincubated with 5 µg/ml HNMPA-(AM)3
bilaterally for 60 min. Insulin (20 nM) was added serosally at time 0.
After 120 min of insulin, 10 µM amiloride was added apically. Results
are means 6 SE; n 5 6. A: actual data for all conditions. B: increase in
short-circuit current (SCC) in response to insulin and relative to the
appropriate control. DSCC is calculated as described in Experimental
Procedures.
Fig. 2. Wortmannin effects on insulin-stimulated sodium transport.
A6 cells were preincubated with wortmannin (25 nM, A; 100 nM, B)
bilaterally for 30 min. Insulin (20 nM) was added serosally at time 0.
After 120 min of insulin, 10 µM amiloride was added apically. Results
are means 6 SE; n 5 4 in A; n 5 2, B.
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pp70 S6 kinase is involved in insulin-stimulated so-
dium transport, A6 cells were pretreated with rapamy-
cin, an inhibitor of pp70 S6 kinase. At all of the
concentrations used, 10 nM, 50 nM (not shown), or 100
nM (Fig. 8A), insulin-stimulated sodium transport was
not inhibited. An IC50 of 0.5–1.0 nM has been reported
for this inhibitor in Chinese hamster ovary cells (26).
However, rapamycin did inhibit insulin-stimulated S6
kinase activity in pp70 S6 kinase immunoprecipita-
tions from the A6 cell (Fig. 8B), indicating that pp70 S6
kinase, although present in A6 cells and inhibited by
Fig. 3. 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyren-4-one (LY-294002)
inhibits insulin-stimulated sodium transport in a concentration-depen-
dent manner. A6 cells were preincubated in LY-294002 bilaterally for 30
min. LY-294002 was added at final concentrations of 2 (A), 10 (B), and 50
(C) µM, as indicated. Insulin (20 nM) was added serosally at time 0.
Results are means 6 SE; n 5 4.
Fig. 4. Dose-response curve for the effect of LY-294002 on insulin-
stimulated sodium transport. Data depicted in Fig. 3 were used to
construct a limited dose-response relationship. The %DSCC of insulin
alone at 30 min after insulin addition are plotted vs. concentration of
LY-294002 (log scale). Results are means 6 SE; n 5 4.
Fig. 5. Initial response to insulin, in which paired data represent
initial response to insulin in A6 cells. Results are means 6 SE; n 5 4.
Fig. 6. In vitro PI 3-kinase activity. Serum-starved (16-h) A6 cells
were treated with (I) or without (CT) 100 nM insulin for 5 min and
solubilized. Solubilized proteins were immunoprecipitated with
anti-PI 3-kinase 85-kDa subunit. Immunoprecipitates were assayed
for activity with or without 25 nM wortmannin (W) or 50 µM
LY-294002 (LY); lipids were extracted and separated by thin-layer
chromatography (TLC). Arrow indicates phosphatidylinositol
(PtdIns) monophosphate. Data are representative of 5 experiments.
E614 PI 3-KINASE AND INSULIN-STIMULATED SODIUM TRANSPORT






rapamycin, is not involved in insulin-stimulated so-
dium transport.
DISCUSSION
Previous work has demonstrated that insulin stimu-
lates the amiloride-sensitive epithelial sodium channel
in models of the distal nephron. The mechanism of how
basolaterally presented insulin can affect the channel
in the apical membrane has not been elucidated. We
have previously demonstrated that insulin specifically
binds the basolateral membrane of amphibian cells and
that the insulin receptor is immunologically localized to
the same membrane (5). In this report, we demonstrate
that an inhibitor of the IRTK, HNMPA-(AM)3, can
inhibit insulin-stimulated sodium transport (Fig. 1).
However, it should be noted that HNMPA-(AM)3 also
has an effect on basal transport, so we cannot exclude
effects of the inhibitor on tyrosine kinases other than
the insulin receptor.
Insulin has pleiotropic effects mediated by several
postreceptor signaling pathways. A key enzyme acti-
vated by insulin is PI 3-kinase. Activation of this
enzyme is required for the insertion of the insulin-
sensitive glucose transporter (GLUT-4) into the plasma
membrane and for activation of pp70 S6 kinase, which
is involved in protein synthesis. We used a specific
inhibitor of PI 3-kinase, LY-294002, to demonstrate
that insulin-stimulated sodium transport also requires
activation of this enzyme (Fig. 3). Because intracellular
pathways are stimulated before the manifestation of a
final effect on transcellular transport, we measured PI
3-kinase activity in the very early phase of the insulin
response. PI 3-kinase is present in A6 cells and can be
inhibited both in vitro (Fig. 6) and in vivo (Fig. 7) by
Fig. 7. In vivo PI 3-kinase activity.
Serum-starved (16-h) A6 cells were
metabolically labeled with 32Pi for 2 h,
followed by 20 min with or without 25
nM wortmannin or 50 µM LY-294002.
Preliminary experiments determined
that stimulation for 1 min with 100 nM
insulin (data not shown) was sufficient for
production of detectable phosphatidylino-
sitol 3,4,5-trisphosphate [PtdIns(3,4,5)P].
After stimulation with insulin, cells were
harvested, and lipids were extracted
and separated by TLC. Phosphorylated
PtdIns were extracted from TLC plates,
deacylated, and analyzed by anion-
exchange HPLC. [3H]PtdIns(4)P and
[3H]PtdIns(4,5)P were used as internal
standards (Std). Data are representa-
tive of 3 experiments.
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LY-294002. The inability of wortmannin to completely
inhibit PI 3-kinase in these cells (Fig. 2) may be
characteristic of Xenopus laevis; others have reported a
PI 3-kinase with similar sensitivities to LY-294002 and
wortmannin in Xenopus laevis oocytes (29). Although
the initial effects of LY-294002 and wortmannin were
similar, the wortmannin effect was not sustained over
time and was less complete than that of LY-294002. Our
functional assay provides a unique opportunity to
monitor the inhibitor effect continuously over long time
courses and may, therefore, detect interactions or ef-
fects that are not easily assessed in other systems.
In Chinese hamster ovary cells, activation of PI
3-kinase is necessary for pp70 S6 kinase activation and
subsequent protein synthesis (26). Rapamycin, an im-
munosuppressant and inhibitor of pp70 S6 kinase, was
used to reveal that pp70 S6 kinase is not involved in
insulin-stimulated sodium transport (Fig. 8A). Al-
though the pp70 S6 kinase is present in A6 cells, is
activated by insulin, and can be inhibited by rapamycin
(Fig. 8B), it does not appear to be involved in the
natriferic effect of insulin.
Insulin-activated PI 3-kinase is necessary for the
translocation of GLUT-4 from a cytosolic pool of vesicles
to the plasma membrane of adipocytes and skeletal
muscle. Although the steps downstream of PI 3-kinase
are not known, it is thought that the activation of PI
3-kinase brings the enzyme to its substrates (PtdIns) in
the membrane and that the lipids are the mediators of
insulin signaling (17). We would suggest that this
pathway may also be utilized for insulin-stimulated
sodium transport.
Several groups have demonstrated that insulin in-
duces an increase in the number of active sodium
channels in the apical membrane. Preliminary reports
indicate that insulin increases channel density in the
apical membranes of A6 cells (2, 4). Published experi-
ments demonstrate that insulin increases the apical
membrane area and the number of open sodium chan-
nels in the apical membrane (11). These results suggest
that insulin induces the exocytotic insertion of sodium
channels into the apical membrane. This hypothesis is
supported by experiments with brefeldin A, an inhibi-
tor of exocytosis, which also inhibits insulin-stimulated
sodium transport (9). Conversely, patch-clamp experi-
ments demonstrated an insulin-stimulated increase in
Po, the sodium channel. These results could not be
confirmed by using noise analysis (4). The reasons for
this discrepancy are not obvious, and we can only
suggest that blocker-induced noise analysis is a less
invasive procedure that will not perturb potential
signaling pathways, such as those involving the cellu-
lar cytoskeleton.
There is precedence for transporters to be translo-
cated in response to stimuli. In addition to GLUT-4,
water channels (aquaporin) are inserted into the apical
membrane of amphibian skin and urinary bladder and
mammalian kidney epithelia in response to antidi-
uretic hormone (16); in stimulated gastric parietal
cells, H1-K1-ATPase is redistributed to the apical sur-
face (15); and the number of H1 ATPases found in turtle
bladder apical membrane increases in response to
carbon dioxide (6). Thus the hypothesis that sodium
channels are exocytotically inserted into the apical
membrane in response to insulin is reasonable.
PI 3-kinase has recently been shown to mediate
epidermal growth factor (EGF) stimulation of intesti-
nal NaCl absorption and Na1/H1 exchange (18). The
ion transport occurs at the ileal brush-border mem-
brane; the EGF receptor is located at the basolateral
membrane. The authors suggest that PI 3-kinase may
be directly associating with Na1/H1 exchangers, be-
cause the SH3 domain of the PI 3-kinase 85-kDa
subunit could interact with proline-rich sequences in
the exchanger. Similarly, the a-subunit of the sodium
channel also contains proline-rich regions (28) that
may directly interact with PI 3-kinase in A6 cells.
These are suggestive of interactions within the proline-
rich region of effector proteins. However, it is also
possible that the lipid products of PI 3-kinase can
directly interact with effectors and regulate activity. In
this regard, it is unclear whether PI(3,4)P2 or PI(3,4,5)P3
(PIP3) would be the crucial product for signal transduc-
Fig. 8. Effects of 100 nM rapamycin on insulin-stimulated sodium
transport and pp70 S6 kinase. A: A6 cells were pretreated with 100
nM rapamycin bilaterally for 30 min. Insulin (20 nM) was added
serosally at time 0. After 120 min of insulin, 10 µM amiloride was
added apically. Results are means 6 SE; n 5 9. B: serum-starved A6
cells were treated with or without 100 nM rapamycin for 30 min,
followed by 5 min with or without 100 nM insulin. Solubilized
proteins were immunoprecipitated with anti-pp70 S6 kinase. Immu-
noprecipitates were assayed for activity. Results are expressed as
multiples of control level, means 6 SE; n 5 5. *P , 0.05 vs. control;
**P , 0.01 vs. rapamycin and insulin.
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tion in this system. Both molecules have been shown to
regulate various signaling systems (30). However, it is
interesting to note that LY-294002 inhibits PIP3 produc-
tion and (subsequently) sodium transport, whereas
wortmannin has no effect on PIP3 production and little
sustained effect on sodium transport in these cells.
However, more experiments need to be performed
before it is possible to state that PIP3 is the crucial
product for signaling in this epithelium or whether the
PI 3-kinase may have a more direct action on the
channel components.
In conclusion, we demonstrate for the first time that
PI 3-kinase is necessary for insulin-stimulated sodium
transport. We suggest that insulin may induce the
insertion of sodium channels into the apical membrane
of A6 cells in a manner analogous to insulin-stimulated
translocation of GLUT-4.
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